Amgis Lifescience Limited, a active public limited company, was established on 22 September 1971 in Vapi, Gujarat, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U99999GJ1971PLC109282. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.50 Cr.
Formerly known as Amardeep Chemicals Industries Private Limited, Amardeep Chemicals Industries Limited. It upholds a compliant status. Its leadership includes Shantaben Dharmendrabhai Patel (Director), Dharmendrabhai Mulchandbhai Patel (Director), Yash Dharmendrabhai Patel (Whole-Time Director). Past directors included Hemang Chandrakant Joshi, Himanshu Sumantrai Shukla, Himani Himanshu Shukla. It holds ₹63.29 Cr open charges and ₹47.88 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A/2/8, Phase I, Behind Upl Vpi/013, Vapi East, Vapi, Gujarat, 396195.
U99999GJ1971PLC109282
109282
22 September 1971
₹5.00 Cr
₹4.50 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Amgis Lifescience Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shantaben Dharmendrabhai Patel | Director | 19 Aug 2016 | Current |
| Dharmendrabhai Mulchandbhai Patel | Director | 19 Aug 2016 | Current |
| Yash Dharmendrabhai Patel | Whole-Time Director | 06 Dec 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Aug 2012 | Past |
| Pramod Abcsdd | Director | 19 Aug 2016 | Past |
| Pramod Abcsdd | Director | 19 Aug 2016 | Past |
| Pramod Abcsdd | Director | 19 Aug 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amgis Lifescience Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Amgis Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹632,936,500.00
₹478,780,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Dec 2023 | Axis Bank Limited | ₹17.50 Cr | Open |
| 07 May 2022 | Hdfc Bank Limited | ₹1.62 Cr | Open |
| 31 Dec 2021 | Hdfc Bank Limited | ₹44.17 Cr | Open |
| 28 Mar 2021 | Others | ₹1.20 M | Satisfied |
| 28 Mar 2021 | Others | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Amgis Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Amgis Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amgis Lifescience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jaykrishna Bankimbhai Pandya was appointed as a Cfo was appointed as a Cfo on 12 May 2025 & has been associated with this company since 6 months 21 days . was recorded as a recent event.
The activity Amgis Lifescience Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge with Hdfc Bank Limited of Rs. 44.17 Cr registered on 31 Dec 2021 with Charge ID 100533566 was modified on 20 Jun 2024. was recorded as a recent event.
Progress on Amgis Lifescience Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
A charge with Axis Bank Limited amounted to Rs. 17.50 Cr with Charge ID 100869726 was registered on 13 Dec 2023. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited of Rs. 1.62 Cr registered on 07 May 2022 with Charge ID 100586898 was modified on 16 Oct 2023. was completed.
The CIN of Amgis Lifescience Limited is U99999GJ1971PLC109282.
Amgis Lifescience Limited is headquartered at A/2/8, Phase I, Behind Upl Vpi/013, Vapi East, Vapi, Gujarat, 396195.
Amgis Lifescience Limited was incorporated on 22 September 1971.
The current directors of Amgis Lifescience Limited are
The primary industry of Amgis Lifescience Limited is Manufacturing.
Amgis Lifescience Limited is unlisted.
The authorized capital of Amgis Lifescience Limited is ₹5.00 Cr, and the paid-up capital is ₹4.50 Cr.
The compliance status of Amgis Lifescience Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX